Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
NCT04488107
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
FCN-437c
DRUG:
Letrozole 2.5mg
Sponsor
Ahon Pharmaceutical Co., Ltd.
Collaborators
[object Object]
[object Object]
[object Object]